ACHV SCHEDULE 13G/A: SEC filing

Logos Global Management LP and affiliated entities

Filed with the SEC on · accession 0000935836-26-000595

ACHV filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Logos Global Management LP and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 8.6% of Achieve Life Sciences' common stock, including shares, options, and warrants.

Summary of the filing

Logos Global Management LP and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 8.6% of Achieve Life Sciences' common stock, including shares, options, and warrants. The filing is a passive investment disclosure with no stated intent to influence control.

Key details

Shares of common stock beneficially owned by Logos Global Management LP$9.7M
Shares of common stock beneficially owned by Logos Global Master Fund LP$4.2M
Shares of common stock beneficially owned by Logos Opportunities Fund V LP$5.5M
Total shares of common stock outstanding$110.0M
IssuerAchieve Life Sciences, Inc.
Reporting person / investment adviserLogos Global Management LP
General partner of logos global management lpLogos Global Management GP LLC
Reporting person / investment fundLogos Global Master Fund LP
General partner of logos global master fund lpLogos GP LLC
Reporting person / investment fundLogos Opportunities Fund V LP
General partner of logos opportunities fund v lpLogos Opportunities V GP LLC
Control person of logos global management lpArsani William
Control person of logos opportunities v gp llcGraham Walmsley

✦ Ask GOAX AI about this filing — what it means for ACHV, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ACHV?

Click here

Frequently asked questions

What did ACHV file with the SEC on Nov 16, 2026?

ACHV filed a SCHEDULE 13G/A (SEC filing). Logos Global Management LP and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 8.6% of Achieve Life Sciences' common stock, including shares, options, and warrants. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other ACHV SEC filings

Get alerts when ACHV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days